← Back
$NKTR All transactions

NEKTAR THERAPEUTICS

▼ SELL

$ Value

$7K

Shares

9,996

Price

$1

Filed

May 21

Insider

Name

Wilson Mark Andrew

Title

Chief Legal Officer

CIK

0001808356

Roles

Officer

Transaction Details

Transaction Date

2025-05-19

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

314,296

Footnotes

Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person. | This transaction was executed in multiple trades at prices ranging from $0.66 to $0.69 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer. | This number includes 7,107 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).

Filing Info

Accession No.

0000950170-25-075977

Form Type

4

Issuer CIK

0000906709

Wilson Mark Andrew's History

Date Ticker Type Value
2026-02-06 SEPN A $0
2025-11-25 NKTR $34K
2025-11-21 NKTR A $0
2025-11-21 NKTR A $0
2025-08-19 NKTR $18K
2025-08-19 NKTR A $0
2025-05-19 NKTR $7K

Other Insiders at NKTR (90d)

Insider Bought Sold Last
ROBIN HOWARD W
President & CEO
$31K 2026-02-18
Zalevsky Jonathan
Chief R&D Officer
$13K 2026-02-18